Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

11results about How to "Improve dysfunction" patented technology

Active induction type rehabilitation system and equipment based on MI-BCI

The invention discloses an active induction type rehabilitation system and device based on MI-BCI, and belongs to the technical field of brain-computer interfaces. The rehabilitation system comprises an MI-EEG signal acquisition and preprocessing module, a data feature extraction and classification algorithm module and an FNS active induction module. The MI-EEG signal acquisition and preprocessing module acquires original EEG electroencephalogram signals by adopting a signal acquisition mode of combining MI with EEG, and performs data preprocessing; the data feature extraction and classification algorithm module extracts ERD / ERS features of rhythms of an alpha frequency band and a beta frequency band of the electroencephalogram signals through a one-to-many common space mode OVR-CSP method, and then classifies the features through a VGG-LSTMnet network; and the FNS active induction module is used for completing active induction according to the classification result of the data feature extraction and classification algorithm module. The device has the advantage of realizing precise rehabilitation under a non-invasive condition, and active induction can be realized on the basis of a neuromuscular feedback pathway so as to improve the dysfunction of a patient caused by the blockage of the neuromuscular pathway.
Owner:CHINA REHABILITATION RES CENT

Application of plumbagin in the preparation of drugs for combating sarcopenia

The present invention relates to the use of plumbagin in the preparation of a drug for combating sarcopenia. Experiments have shown that plumbagin can improve the muscle mass and strength of sarcopenia model mice, improve functional disorders, and promote myoblast differentiation and myotube fusion, which provides a new drug for the treatment of sarcopenia.
Owner:THE SECOND AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY

Application of herba siegesbeckiae composition in preparation of product for improving heart mitochondrial dysfunction

PendingCN119112976AEnhance myocardial energy metabolismavoid damageCardiovascular disorderPlant ingredientsMyocardial energeticsMFN2
The invention relates to the field of biological medicines, in particular to an application of a siegestistilbene composition in preparation of a product for improving heart mitochondrial dysfunction. According to the application, various experimental technologies such as pharmacodynamic evaluation, systematic biology, molecular biology and the like are applied, the pharmacodynamic effect and the regulation mechanism of XJQ for preventing and treating chronic heart failure are systematically discussed from the animal level, the cell level and the molecular level, and it is clear that XJQ can significantly enhance the heart function of a chronic heart failure mouse induced by pressure load, relieve myocardial damage and inhibit myocardial hypertrophy; the XJQ has the advantages that the XJQ can be used for relieving myocardial fibrosis, so that chronic heart failure is relieved, which is related to up-regulation of PGC-1alpha, activation of a PPARalpha / PGC-1alpha pathway, up-regulation of NRF1, TFAM and Mfn2, down-regulation of Drp1, promotion of mitochondrial biogenesis, inhibition of mitochondrial division, promotion of mitochondrial fusion, improvement of mitochondrial dysfunction and enhancement of myocardial energy metabolism, and the application range of the XJQ is expanded.
Owner:DONGZHIMEN HOSPITAL OF BEIJING UNIV OF CHINESE MEDICINE

Tin Lancea sarcodia polysaccharide with function of improving endothelial cell dysfunction and glycolipid metabolism disorder

The invention discloses a sarcodia stannanensis polysaccharide with functions of improving endothelial cell dysfunction and glucose and lipid metabolism disorder. The polysaccharide is extracted from sarcodia stannanensis by utilizing a compound enzyme. The invention not only provides a theoretical basis for high-value utilization of the sarcodia stannanensis, but also provides a new idea for prevention and treatment of diseases.
Owner:ZHOUSHAN LINGXIAN MARINE BIOTECHNOLOGY CO LTD

A tin selenide-based nanozyme, its preparation method and applications

This invention provides a tin selenide-based nanozyme, comprising tin selenide, with tannic acid and tetravalent cerium ions conjugated on the surface of the tin selenide. The invention also provides a method for preparing the above-mentioned nanozyme, comprising mixing tin selenide with anhydrous ethanol and ultrasonically dispersing the mixture; centrifuging the resulting mixture to obtain a supernatant, further centrifuging the supernatant to obtain a tin selenide nanosheet solution; adding the above tin selenide nanosheet solution and tannic acid solution together to deionized water; subsequently adding cerium nitrate solution and continuing stirring; then adding sodium hydroxide solution to adjust the pH to 8.0; after the reaction is complete, the tin selenide-based nanozyme is obtained. This invention also provides the application of the above-mentioned tin selenide-based nanozyme in the preparation of anti-atherosclerotic drugs. The nanozyme of this invention can effectively alleviate the progression of atherosclerosis.
Owner:SHANGHAI EAST HOSPITAL EAST HOSPITAL TONGJI UNIV SCHOOL OF MEDICINE

Mitochondrial activation miRNA and application of mitochondrial activation miRNA-loaded radix puerariae exosome in targeting resistance to Parkinson's

ActiveCN119055672Aimprove dysfunctionPromote autophagyOrganic active ingredientsNervous disorderDiseaseTherapeutic effect
The invention discloses application of mitochondrial activation miRNA and loaded radix puerariae exosome targeting resistance of the mitochondrial activation miRNA, and belongs to the field of biological application. The miRNA provided by the invention comprises at least one of miRNAs of which the sequences are as shown in SEQ ID No, 1 to SEQ ID No, 23. The radix puerariae exosome and miRNA delivered by the radix puerariae exosome show a good treatment effect on Parkinson's disease, and the radix puerariae exosome and miRNA mainly play a role in improving mitochondrial dysfunction, such as promoting mitochondrial autophagy, improving mitochondrial membrane potential, reducing oxidative stress, maintaining completeness of mitochondrial inner membrane respiratory chain complex and increasing ATP (adenosine triphosphate) generation. The invention further discloses a delivery scheme adopting the exosome which is targeted and modified by neurons and is derived from radix puerariae as the miRNA carrier, the targeting property and the stability of miRNA can be improved, and the problems that miRNA drugs are low in delivery efficiency and easy to degrade are solved. According to the invention, the treatment process of Parkinson's disease is expected to be promoted through the neuron-targeted kudzu vine root exosome and the miRNA delivered by the same.
Owner:ZHEJIANG UNIV

Traditional Chinese medicine composition for treating knee osteoarthritis as well as preparation method and application thereof

The invention provides a traditional Chinese medicine composition for treating knee osteoarthritis as well as a preparation method and application thereof, and belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 15-25 parts of radix cyathulae, 15-25 parts of prepared rehmannia root, 15-25 parts of cynomorium songaricum, 15-25 parts of obscured homalomena rhizome, 15-25 parts of snow lotus herb, 15-25 parts of rhizoma cibotii, 15-25 parts of common fenugreek seed, 15-25 parts of zaocys dhumnade, 10-20 parts of paniculate swallowwort root, 10-20 parts of pine nodular branch, 10-20 parts of corydalis tuber, 10-20 parts of combined spicebush root, 15-25 parts of Chinese angelica, 10-20 parts of ligusticum wallichii, 15-25 parts of Chinese yam, 15-25 parts of poria cocos, 10-20 parts of green tangerine peel, 15-25 The traditional Chinese medicine composition can effectively treat knee osteoarthritis.
Owner:GANSU PROVINCIAL HOSPITAL OF TRADITIONAL CHINESE MEDICINE

Use of pizhizhiu in the preparation of a drug for preventing and / or treating myocardial infarction

The application discloses application of Piancizhu in preparation of a medicine for preventing and / or treating myocardial infarction. The application first discovers that Piancizhu can play an anti-cardiac ischemic injury role by improving heart function of a mouse model of left anterior descending branch stenosis of coronary artery, inhibiting inflammation levels of a heart, peripheral blood and bone marrow after cardiac infarction, reducing a myocardial infarction area and improving cardiac function disorder. Therefore, the application provides a scientific basis for increasing a clinical treatment indication of Piancizhu in acute myocardial infarction, simultaneously provides a new drug selection for clinical treatment of an acute cardiac infarction patient due to a good anti-inflammatory effect, and has a good application prospect.
Owner:HENAN ACADEMY OF MEDICAL SCIENCES +1

Anti-wrinkle tightening and anti-photoaging cyclo-nonapeptide and application thereof

PendingCN122502446AproliferativeIncrease COL1 content
The application discloses an anti-wrinkle and anti-photoaging cyclic nonapeptide and application thereof, and the amino acid sequence of the cyclic nonapeptide is: cyclic (arginine-glycine-aspartic acid-serine-tyrosine-lysine-valine-lysine-arginine). The cyclic nonapeptide RGDSYKVKR of the application can significantly increase the content of COL1 in dermal fibroblasts, down-regulate the matrix metalloproteinase genes MMP1 and MMP3, and reduce the aging markers P21 and P16, thereby playing the roles of promoting collagen generation, improving skin elasticity, and lightening skin wrinkles, and having the effects of anti-aging and anti-wrinkle and anti-aging. The cyclic nonapeptide can also significantly increase the content of COL1 in dermal fibroblasts after UV irradiation, reduce the relative expression of the aging markers MMP1, MMP3 and P53 mRNA in the dermal fibroblasts after UV irradiation, and thereby play the role of anti-photoaging.
Owner:PROYA COSMETICS CO LTD

Medical Uses of Epimedin

ActiveCN115175676Bimprove dysfunctionGood coagulationOrganic active ingredientsPeptide/protein ingredientsDiseasePlatelet dysfunction
The invention discloses a use of icariin in preparing a drug for preventing and treating hemorrhagic diseases, which belongs to the field of medicine. Icariin can improve platelet dysfunction, shorten thromboplastin time, promote blood coagulation, and can be used for the prevention and treatment of hemorrhagic diseases, especially the treatment of hemorrhagic transformation of cerebral infarction, gastrointestinal bleeding caused by thrombolytic drugs or antithrombotic drugs for cerebral infarction, or bleeding complications caused by thrombolytic drugs or antithrombotic drugs for myocardial infarction.
Owner:LUNAN BETTER PHARMA

Composite dali tea and application thereof in improving male reproductive function product

The application belongs to the field of health food, and discloses a compound Dali tea and application of the compound Dali tea in improving male reproductive function products, wherein the compound Dali tea is composed of Dali tea water extract and Yunkang tea water extract; the weight ratio of the Dali tea water extract to the Yunkang tea water extract is 1:1, 2:1 or 3:1. The compound Dali tea can significantly improve the sperm density, activity, survival rate and average moving angle of obese male mice, reduce the sperm abnormality rate, improve the testicular tissue structure and testicular coefficient, and regulate the levels of reproductive related hormones such as testosterone, leptin and insulin, and improve the hypothalamus-pituitary-gonadal axis function disorder. The raw material of the application is natural and safe, the preparation process is simple and controllable, the application can be used for developing food or health products for improving the decline of male reproductive function induced by obesity, and has good application prospect and market value.
Owner:ANHUI AGRICULTURAL UNIVERSITY